KF Biofyr ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 1.9% 1.6%  
Credit score (0-100)  0 0 0 69 69  
Credit rating  N/A N/A N/A A A  
Credit limit (kDKK)  0.0 0.0 0.0 1.4 10.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 8,578 7,124  
EBITDA  0.0 0.0 0.0 3,051 2,860  
EBIT  0.0 0.0 0.0 2,902 2,627  
Pre-tax profit (PTP)  0.0 0.0 0.0 2,847.6 2,601.9  
Net earnings  0.0 0.0 0.0 2,219.8 2,030.3  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 2,848 2,602  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 696 823  
Shareholders equity total  0.0 0.0 0.0 2,816 4,846  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 4,965 6,418  

Net Debt  0.0 0.0 0.0 0.0 0.0  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 8,578 7,124  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -17.0%  
Employees  0 0 0 7 6  
Employee growth %  0.0% 0.0% 0.0% 0.0% -14.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 4,965 6,418  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 29.3%  
Added value  0.0 0.0 0.0 2,902.5 2,860.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 547 -107  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 33.8% 36.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 58.5% 46.2%  
ROI %  0.0% 0.0% 0.0% 100.8% 68.1%  
ROE %  0.0% 0.0% 0.0% 78.8% 53.0%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 56.7% 74.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% 0.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 1.3 3.0  
Current Ratio  0.0 0.0 0.0 2.0 3.7  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 2,182.6 4,076.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 415 477  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 436 477  
EBIT / employee  0 0 0 415 438  
Net earnings / employee  0 0 0 317 338